H.R. 2520 (109th): Stem Cell Therapeutic and Research Act of 2005

Introduced:

May 23, 2005
109th Congress, 2005–2006

Status:

Enacted — Signed by the President on Dec 20, 2005

This bill was enacted after being signed by the President on December 20, 2005.

Law:

Pub.L. 109-129

Sponsor:

Christopher “Chris” Smith

Representative for New Jersey's 4th congressional district

Republican

Text:

Read Text »
Last Updated: Dec 19, 2005
Length: 14 pages

About the bill

Full Title

To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program.

Read CRS Summary >

History

May 23, 2005
 
Introduced

This is the first step in the legislative process.

May 24, 2005
 
Passed House

The bill was passed in a vote in the House. It goes to the Senate next.

Dec 16, 2005
 
Passed Senate with Changes

The Senate passed the bill with changes not in the House version and sent it back to the House to approve the changes. The vote was by Unanimous Consent so no record of individual votes was made.

Dec 17, 2005
 
House Agreed to Changes

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill.

Dec 17, 2005
 
Text Published

Updated bill text was published as of Passed the Senate (Engrossed) with an Amendment.

Dec 20, 2005
 
Enacted — Signed by the President

The President signed the bill and it became law.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: